title: Breakthrough bacteraemia with a susceptible Enterococcus faecalis during tigecycline monotherapy.
authors.affiliation: Department of Infection & Tropical Medicine, Castle Hill Hospital, Hull and East Yorkshire Hospitals NHS Trust, Cottingham, East Yorkshire HU16 5JT, UK. mparsonage@btopenworld.com
authors.forename: Mirella
authors.initials: M
authors.lastname: Parsonage
authors.forename: Shital
authors.initials: S
authors.lastname: Shah
authors.forename: Peter
authors.initials: P
authors.lastname: Moss
authors.forename: Hiten
authors.initials: H
authors.lastname: Thaker
authors.forename: Rolf
authors.initials: R
authors.lastname: Meigh
authors.forename: Ariyur
authors.initials: A
authors.lastname: Balaji
authors.forename: James
authors.initials: J
authors.lastname: Elston
authors.forename: Gavin
authors.initials: G
authors.lastname: Barlow
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology*; D013293:Enterococcus faecalis / Q000187:drug effects* / Q000302:isolation & purification; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D008911:Minocycline / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000078304:Tigecycline
chemical_list: D000900:Anti-Bacterial Agents; D000078304:Tigecycline; D008911:Minocycline